Skip to content

Feed Screener Search MCP Methodology

SEC · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
AMF · FR
BAFIN · DE

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search MCP Methodology

Pricing Sign in

Bernard Gilly — GENSIGHT BIOLOGICS S.A. insider: 1 transactions · InsiderLens

Home / Insiders / Bernard Gilly

Bernard Gilly

Directeur Général at GENSIGHT BIOLOGICS S.A. · on record since Apr 11, 2022

Insider trading activity of Bernard Gilly

Transactions on record: 1; since Apr 11, 2022

Open-market buys: 1

Open-market sells: 0

Companies traded: 1; last filing Apr 11, 2022

Figures computed from official regulatory filings — methodology.

Companies where Bernard Gilly has traded

GENSIGHT BIOLOGICS S.A.1 tx · Apr 11, 2022

Track record of Bernard Gilly

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Bernard Gilly

Co-insiders of Bernard Gilly

Sofinnova Partners SASGENSIGHT BIOLOGICS S.A.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

Company	Filed	Type	Qty	Price	Value · USD	Src
GENSIGHT BIOLOGICS S.A.	Apr 11, 2022	Buy	50,000	2.34 EUR	—	AMF